CESAR'S HYGIENE LIMITED
REGISTERED NUMBER: 09355744
BALANCE SHEET
AS AT 31 DECEMBER 2023
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
Creditors: amounts falling due after more than one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
Cesar's Hygiene Limited is a private limited liability company with share capital incorporated in England and Wales under company number 09355744. The company's registered office and principal place of business is 71 Howlands, Welwyn Garden City, Hertfordshire AL7 4RA.
Average number of employees
|
The average monthly number of employees, including directors, during the year was 1 (2022 - 1).
Directors' benefits: advances, credits and guarantees
|
The director maintains a loan account with the company. At the beginning of the year the director owed the company £14,593. During the year there were advances to the director of £31,703 (2022: £46,089) and repayments of £33,000 (2022: £51,402). During the year interest was charged of £503 and no amounts were written off. At the year end date the director owed the company £13,799.
|
CESAR'S HYGIENE LIMITED
REGISTERED NUMBER: 09355744
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2023
Director's confirmations
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 September 2024.
|